Abstract
We have previously demonstrated that normal human oral keratinocytes immortalized by transfection with human papillomavirus type-16 Dna became tumorigenic after exposure to a chemical carcinogen. In an effort to detect differentially regulated genes associated with this transition from the immortal to the malignant phenotype, we employed representational differences analysis (a PCR-coupled subtractive hybridization technique). After analysing 50 colonies, 12 putative messages were identified. Northern analysis comparison using the identified cDNAs as probes was made between normal human oral keratinocyte, papillomavirus-immortalized human oral keratinocytes (HOK-16B), a neoplastic cell line derived from HOK-16B (HOK-16B-BaP-T) and the human oral cancer cell lines Hep-2, SCC-9 and Tu-177. We found that mRNAs encoding for cyclophilin A, c-myc binding protein 1, the heat shock protein 90α and one unknown transcript were up-regulated in the oral cancer cell lines analysed as well as in HOK-16B cells. We also detected a downregulation of the mRNAs encoding the skin-derived antileukoproteinase SKALP/elafin, the translationally regulated p23 protein and one unknown transcript. Whether these messages are associated to the neoplastic conversion of human keratinocytes remains to be determined.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahn JH and Hayward GS. . 1997 J. Virol. 71: 4599–4613.
Aligue R, Akhavan-Niak and Russel P. . 1994 EMBO J. 13: 6099–6106.
Alkemade HAC, Molhuizen HO, Ponec M, Kempenaar Ja, Zeeuwen PLJM, de Jongh GJ, van Vlijmen-Willems IMJJ, van Erp PEJ, van de Kerkhof and Schalkwijk J. . 1994 J Cell Science 107: 2335–2342.
Alkemade HAC, Molhuizen HO, van Vlijmen-Willems IMJJ, van Haelst UJGm and Schalkwijk J. . 1993 Am. J. Pathol. 143: 1679–1687.
Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ. . 1997 Nucleic Acids Res. 25: 3389–3402.
Asano K, Merrick WC and Hershey WB. . (1997) J. Biol. Chem. 272: 23477–23480.
Barbosa JS, Edmonds C, Fisher C, Schiller JT, Lowy DR and Vousdan KH. . 1990 EMBO J. 9: 153–160.
Bishop JM. . 1987 Science 235: 305–311.
Böhm H, Benndorf R, Gestel M, Gross B, Nürnberg P, Kraft R, Otto A and Bielka H. . 1989 Biochem. Int. 19: 277–286.
Carvalho T, Seeler JS, Ohman K, Jordan P, Pettersson U, Akusjarvi G, Carmofonseca M and Dejean A. . 1995 J. Cell. Biol. 131: 45–56.
Chang F, Syrjanen S, Nuttinen J, Karje J and Syrjanen K. . 1990 Arch. Dermatol. Res. 282: 493–497.
Cohen SM and Ellwein LB. . 1990 Science 249: 1007–1011.
Desbois C, Rousset R, Bantignies F and Janot P. . 1996 Science 273: 951–953.
Deblandre GA, Marinx OP, Evans SS, Majjaj S, Leo O, Caput D, Huez GA and Wathelet MG. . 1995 J. Biol. Chem. 270: 23860–23866.
Di Luca D, Sacks P and Adler-Stothz K. . 1990 J. Dent. Res. 69: 51.
Durst M, Gissmann L, Ikenburg H and zur Hausen H. . 1983 Proc. Natl. Acad. Sci. USA 80: 3812–3815.
Fu XD and Maniatis T. . 1992 Science 256: 535–538.
Gissmann L, Boshart M, Durst M, Ikenburg H, Wagner D and zur Hausen H. . 1984 J. Invest. Dermatol. 86: 26s–28s.
Haendler B, Hofer-Warbinek R and Hofer E. . 1987 EMBO J. 6: 947–950.
Hubank M and Schatz DG. . 1994 Nucleic Acid Res. 22: 5640–5648.
Li WZ, Lin P, Frydman J, Boal TR, Cardillo TS, Richard ML, Toth D, Lichtman MA, Hartl FU and Sherman F. . 1994 J. Biol. Chem. 269: 18616–18622.
Lindquist S and Craig EA. . 1982 Annu. Rev. Genet. 22: 631–677.
Lisitsyn N, Lisitsyn N and Wigler M. . 1993 Science 259: 949–951.
Maul GG and Everett RD. . 1994 J. Gen. Virol. 75: 1223–1233.
Meanwell CA. . 1988 Cancer Surv. 7: 481–487.
Min B-M, Baek J-H, Shin K-H, Gujuluva Cn, Cherrick M and Park N-H. . 1994 Eur. J. Cancer 30B: 338–345.
Molhuizen HOF, Alkemade HAC, Zeeuwen PLJM, de Johgh GJ, Wieringa B and Schalkwijk J. . 1993 J. Biol. Chem. 268: 12028–12032.
Morozov A, Subjeck J and Raychaudhuri P. . 1995 FEBS letts. 371: 214–218.
Mullen MA, Gerstberger S, Ciufo DM, Mosca JD and Hayward GS. . 1995 J. Virol. 69: 476–491.
Nothwang HG, Tamura T, Tanaka K and Ichihara A. . 1994 Biochim. Biophys. Acta 1219: 361–368.
Park N-H, Gujulava CN, Baek J-H, Cherrick HM, Shin K-H and Min B-M. . 1995 Oncogene 10: 2145–2153.
Puvion-Dutilleul F, Chelbi-Alix MK, Koken M, Quignon F, Puvion E and De Thé H. . 1995 Exp. Cell. Res. 218: 9–16.
Radice P, Pensotti V, Jones C, Perry H, Pierotti MA and Tunnacliffe A. . 1995 Genomics 26: 101–106.
Ray R and Miller DM. . 1991 Mol. Cell. Biol. 11: 2154–2161.
Ray R. . 1995 Cell Growth Differ. 6: 1089–1096.
Schwartz E, Feese UK, Gissmann L, Mayer W, Roggenbuck B, Stremaau A and zur Hausen H. . 1985 Nature 314: 111–114.
Shaffer Jr EL, Reimann BEF and Gysland WB. . 1980 J. Oral Pathol. 9,: 163–173.
Simon MC, Kitchener K, Kao HT, Hickey E, Weber L, Voellmy R, Heintz N and Nevins JR. . 1987 Mol. Cell. Biol. 7: 2884–2890.
Song HY, Dunbar JD, Zhanag YX, Guo D and Donner DB. . 1995 J. Biol. Chem. 270: 3574–2581.
Spitz MR, Fueger JJ, Goepfert H, Hong WK and Newell RR. . 1995 Cancer 61: 203–208.
Summers L and Booth DR. . 1977 Oral Surg. 38: 273–278.
Sureau A, Soret J, Vellard M, Crochet J and Perbal B. . 1992 Proc. Natl. Acad. Sci. USA 89: 11683–11687.
Syrjanen KJ, Pyrhonen S, Syrjanen SM and Lamberg MA. . 1983 Br. J. Oral Surg. 21: 143–153.
Syrjanen S. . 1992 Scand. J. Dent. Res. 100: 17–31.
Syrjanen SM, Syrjanen KJ and Lamberg MA. . 1986 Oral Surg. 62: 660–667.
Vellard M, Sureau A, Soret J, Martineirie C and Perbal B. . 1992 Proc. Natl. Acad. Sci. USA 89: 2511–2515.
Yamazaki M, Akaogi K, Miwa T, Imai T, Soeda E and Yokoyama K. . 1992 Nucleic Acids Res. 17: 7108.
Yeudall WA. . 1992 Eur. J. Cancer 28B: 61–66.
zur Hausen H. . (1977) Curr. Top. Microbiol. Immunol. 778: 1–30.
Acknowledgements
We would like to thank Bradley Ackerson and Wentong Guo for critical reading of this manuscript. This work was, in part, supported by grants DE11728 and DE10598 from the National Institute of Dental Research.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rey, O., Baluda, M. & Park, NH. Differential gene expression in neoplastic and human papillomavirus-immortalized oral keratinocytes. Oncogene 18, 827–831 (1999). https://doi.org/10.1038/sj.onc.1202328
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1202328
Keywords
This article is cited by
-
Novel combinational treatment of cisplatin with cyclophilin a inhibitors in human heptocellular carcinomas
Archives of Pharmacal Research (2010)
-
The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis
Oncogene (2009)
-
Knockdown endogenous CypA with siRNA in U2OS cells results in disruption of F-actin structure and alters tumor phenotype
Molecular and Cellular Biochemistry (2009)
-
Identification of Tumor-Associated Proteins in Well Differentiated Laryngeal Squamous Cell Carcinoma by Proteomics
Clinical Proteomics (2007)
-
Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21
Oncogene (2002)